Hangzhou Tigermed Consulting Co (SZSE:300347) Margin of Safety % (DCF FCF Based) : -97.84% (As of Apr. 29, 2024)

View and export this data going back to 2012. Start your Free Trial

What is Hangzhou Tigermed Consulting Co Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

As of today (2024-04-29), Hangzhou Tigermed Consulting Co's Predictability Rank is 4.5-Stars. Hangzhou Tigermed Consulting Co's intrinsic value calculated from the Discounted FCF model is ¥61.75 and current share price is ¥59.67. Consequently,

Hangzhou Tigermed Consulting Co's Margin of Safety % (DCF FCF Based) using Discounted FCF model is -97.84%.

Competitive Comparison of Hangzhou Tigermed Consulting Co's Margin of Safety % (DCF FCF Based)

For the Diagnostics & Research subindustry, Hangzhou Tigermed Consulting Co's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hangzhou Tigermed Consulting Co's Margin of Safety % (DCF FCF Based) Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Hangzhou Tigermed Consulting Co's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Hangzhou Tigermed Consulting Co's Margin of Safety % (DCF FCF Based) falls into.

Hangzhou Tigermed Consulting Co Margin of Safety % (DCF FCF Based) Calculation

Hangzhou Tigermed Consulting Co's Margin of Safety % (DCF FCF Based) for today is calculated as

Margin of Safety % (DCF FCF Based)	=	(Intrinsic Value: DCF (FCF Based)	-	Current Price)	/	Intrinsic Value: DCF (FCF Based)
	=	(30.16	-	59.67)	/	30.16
	=	-97.84 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The intrinsic value is calculated from the Discounted FCF model with default parameters. The calculation method is the same as Discounted Earnings model except free cash flow are used in the calculation instead of earnings per share.

Hangzhou Tigermed Consulting Co Margin of Safety % (DCF FCF Based) Related Terms

Thank you for viewing the detailed overview of Hangzhou Tigermed Consulting Co's Margin of Safety % (DCF FCF Based) provided by GuruFocus.com. Please click on the following links to see related term pages.

Hangzhou Tigermed Consulting Co (SZSE:300347) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Hangzhou Tigermed Consulting Co Ltd (SZSE:300347) » Definitions » Margin of Safety % (DCF FCF Based)

Comparable Companies

Traded in Other Exchanges

HNGZY:USA 03347:Hong Kong

Address

Block 8, No. 19 Jugong Road, Room 2001-2010, 20th Floor, Xixing Sub-District, Binjiang District, Hangzhou, CHN, 310053

Website

https://www.tigermed.net

Hangzhou Tigermed Consulting Co Ltd is a China-based Contract Research Organization. The company's segment includes Clinical trial solutions and Clinical-related and laboratory services. It generates maximum revenue from the Clinical trial solutions segment. The company's offered services include bioanalytical, medical writing, biostatistics analysis, and medical imaging. The therapeutic areas of the company include Infections, Hematology, Cardiovascular, Endocrinology, Rheumatology, Nephrology, and Central Nervous System (CNS) among others.

Hangzhou Tigermed Consulting Co (SZSE:300347) Headlines

No Headlines